The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus
Objectives. This review assesses the polypharmacy reduction potential of cinnamic acids (CAs) and some related compounds in managing three or more of the cluster of seven, pre- and post-type 2 diabetes mellitus (T2DM)-related features (central obesity, hyperglycemia, hypertension, dyslipidemia, pro-...
Guardado en:
Autores principales: | Barre Douglas Edward, Mizier-Barre Kazimiera Amelia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Sciendo
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/06705b0aa79147eea4938b0cd749301c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Selected 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors. A look into their use and potential in pre-diabetes and type 2 diabetes
por: Barre Douglas Edward, et al.
Publicado: (2021) -
Maturity-Onset Diabetes of Young Type 5: Diabetes with Extrapancreatic Features
por: Adnan Haider, et al.
Publicado: (2021) -
Comparison of clinical and biochemical variables in type 2 diabetes mellitus patients and their first-degree relatives with metabolic syndrome in Benin City, Nigeria: A cross sectional case controlled study
por: Ogedengbe S, et al.
Publicado: (2016) -
The Multiple Roles of B Lymphocytes in the Onset and Treatment of Type 1 Diabetes: Interactions between B Lymphocytes and T Cells
por: Yangfan Xiao, et al.
Publicado: (2021) -
Longitudinal associations between family conflict, parent engagement, and metabolic control in children with recent-onset type 1 diabetes
por: Susana R Patton, et al.
Publicado: (2021)